This series of talks will focus on how to appropriately position neuromodulation therapies and compare with other therapies based on Safety, Appropriateness, Fiscal Neutrality, and Effectiveness.
Samuel Cheshier, MD, PhD
The practice of neuromodulation involves more than just technical proficiency. This plenary session explores some of the socioeconomic aspects of the practice of neuromodulation.
The Late-Breaking Clinical Trial session emphasizes the most recent and groundbreaking research in the field of neuromodulation.
Ellen L. Air, MD PhD; Nebojsa Nick Knezevic, MD PhD
Erika Petersen, MD
Bradford Jones, DO
Guilherme Santos Piedade, MD
Leonardo Kapural, MD PhD
John Markman, MD
Anuj Bhatia, MD PhD
The accepted indications for brain neuromodulation are growing. However, what is the quality of the scientific evidence behind the current clinical uses of brain neuromodulation? This session will explore the extant level of evidence behind brain neuromodulation for a variety of neurologic disorders
Heather Pinckard-Dover, MD